Mason Wells has sold Nelipak Healthcare Packaging to Kohlberg & Company
Headquartered in Cranston, Rhode Island, Nelipak is a leading global provider of custom designed rigid packaging for the medical device and pharmaceutical industries. The company’s products include thermoformed medical trays and blisters, pharmaceutical handling trays, surgical procedure trays and lidding materials. Nelipak’s products are primarily designed for Class II and Class III medical devices, which are high value, implantable devices. Nelipak has a diverse, global customer base consisting of some of the world’s leading medical device manufacturers and pharmaceutical companies. Nelipak’s seven facilities are located in Arizona, Pennsylvania, Rhode Island, The Netherlands, Ireland, Puerto Rico and Costa Rica.
Lincoln acted as the exclusive financial advisor to Mason Wells and Nelipak, working closely with the shareholders and management team during the sale process. This included providing advisory expertise and managing the preparatory, marketing, due diligence and negotiation phases of the transaction. Terms of the transaction were not disclosed.
Lincoln ran a competitive, disciplined process that, when combined with their in-depth knowledge of the healthcare packaging and medical device outsourcing sectors, generated very strong enthusiasm for Nelipak and resulted in a successful outcome for the company and its shareholders.
Meet our Senior Team
View More Transactions
Lincoln International is pleased to announce that it has advised The Vet Connection on its sale to Pets at Home Group PLC (LSE:PETS)
Lincoln International is pleased to announce that it has advised shareholders and management of Corndel, the UK's fastest growing leadership and digital skills training company, on its investment from THI Investments
Lincoln International is pleased to announce that Evans Capacitor Company has been sold to Arcline Investment Management
Lincoln International is pleased to announce that it has advised the shareholders of ASSEPRO, the leading independent Swiss insurance broker, on its sale to EMZ Partners